Redirect Notice
 The previous page is sending you to https://me-7.com/news/adding-multimedia-fda-approves-genentechs-evrysdi-risdiplam-for-treatment-of-spinal-muscular-atrophy-sma-in-adults-and-children-2-months-and-older-business-wire.html.

 If you do not want to visit that page, you can return to the previous page.